Medical Industry Today
SEE OTHER BRANDS

Bringing you the latest news on healthcare and wellness

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Industry Today.

TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Expedited Programs for Regenerative Medicine Therapies for Serious Conditions

Expedited Programs for Regenerative Medicine Therapies for Serious Conditions

Docket Number: FDA-2017-D-6159 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research, Office of Therapeutic Products This guidance provides sponsors engaged in the development of regenerative medicine therapies for...

Owner:  American Government
Senedd 2026 | The road to recovery: RCP manifesto launch

Senedd 2026 | The road to recovery: RCP manifesto launch

This month, RCP vice president for Wales Dr Hilary Williams blogs about our manifesto launch, Jeremy Miles’ announcement on physician assistants and implementation of the Leng review recommendations in Wales, and Swansea University’s Welsh Learner...

Owner:  Royal College of Physicians (Non-profit)
Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products

Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products

Docket Number: FDA-2017-D-6159 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research, Office of Therapeutic Products The purpose of this guidance is to discuss methods and approaches for capturing postapproval safety and...

Owner:  American Government
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations

Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations

Docket Number: FDA-2025-D-3403 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research, Office of Therapeutic Products This guidance provides recommendations to sponsors who are planning clinical trials of cell and gene...

Owner:  American Government
Media Networks Sydney Pty. Limited - 711342 - 09/16/2025

Media Networks Sydney Pty. Limited - 711342 - 09/16/2025

Delivery Method: VIA EMAIL WITH READ RECEIPT Reference #: 320-25-110 Product: Drugs Over-the-Counter Drugs Recipient: Recipient Name Mr. Gilad Wielunski Media Networks Sydney Pty. Limited 36 Mid Dural Rd. Galston NSW 2159 Australia Issuing Office:...

Owner:  American Government
Pharmacovigilance Outsourcing Market Size Worth USD 12.12 Billion by 2034 Driven by Rising Clinical Trials and Stringent Regulations
Aluminum Foil Market Size to Worth USD 48.46 Billion by 2034
District court denies preliminary injunctions by drug companies in challenges to Maine’s 340B contract pharmacy law
DHS proposes weighted selection process for new H-1B registrations and petitions
Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes
TOMI Environmental Solutions Announces Specialized Service Provider for Healthcare and Mold Remediation
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
Energy Healer Adrienne Cummings of Addie’s Heart Centered Healing Recently Featured on Close Up Radio
Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
Liquid Handling Systems Market Size Expected to Reach USD 6.94 Billion by 2034 Driven by Rising Demand in Clinical Diagnostics and Genomics
Maria C. Diaz Agosto Named 2025 Honoree for Leadership in Healthcare and Bold Reinvention
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
RSi Wins 2025 Top Workplaces Healthcare Industry Award, A National Recognition

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions